Individual exposures to drinking water trihalomethanes, low birth weight and small for gestational age risk: a prospective Kaunas cohort study by Grazuleviciene, Regina et al.
RESEARCH Open Access
Individual exposures to drinking water
trihalomethanes, low birth weight and small for
gestational age risk: a prospective Kaunas cohort
study
Regina Grazuleviciene
1*, Mark J Nieuwenhuijsen
2†, Jone Vencloviene
1†, Maria Kostopoulou-Karadanelli
3†,
Stuart W Krasner
4†, Asta Danileviciute
1†, Gediminas Balcius
1† and Violeta Kapustinskiene
1†
Abstract
Background: Evidence for an association between exposure during pregnancy to trihalomethanes (THMs) in
drinking water and impaired fetal growth is still inconsistent and inconclusive, in particular, for various exposure
routes. We examined the relationship of individual exposures to THMs in drinking water on low birth weight (LBW),
small for gestational age (SGA), and birth weight (BW) in singleton births.
Methods: We conducted a cohort study of 4,161 pregnant women in Kaunas (Lithuania), using individual
information on drinking water, ingestion, showering and bathing, and uptake factors of THMs in blood, to estimate
an internal dose of THM. We used regression analysis to evaluate the relationship between internal THM dose and
birth outcomes, adjusting for family status, education, smoking, alcohol consumption, body mass index, blood
pressure, ethnic group, previous preterm, infant gender, and birth year.
Results: The estimated internal dose of THMs ranged from 0.0025 to 2.40 mg/d. We found dose-response
relationships for the entire pregnancy and trimester-specific THM and chloroform internal dose and risk for LBW
and a reduction in BW. The adjusted odds ratio for third tertile vs. first tertile chloroform internal dose of entire
pregnancy was 2.17, 95% CI 1.19-3.98 for LBW; the OR per every 0.1 μg/d increase in chloroform internal dose was
1.10, 95% CI 1.01-1.19. Chloroform internal dose was associated with a slightly increased risk of SGA (OR 1.19, 95%
CI 0.87-1.63 and OR 1.22, 95% CI 0.89-1.68, respectively, for second and third tertile of third trimester); the risk
increased by 4% per every 0.1 μg/d increase in chloroform internal dose (OR 1.04, 95% CI 1.00-1.09).
Conclusions: THM internal dose in pregnancy varies substantially across individuals, and depends on both water
THM levels and water use habits. Increased internal dose may affect fetal growth.
Background
The association between exposure to disinfection by-
products (DBPs), as measured by trihalomethanes
(THMs), in drinking water and adverse reproductive/
developmental effects has been extensively studied in
recent epidemiological studies. Some epidemiological
studies suggested that pregnant women exposed to
water containing elevated THMs concentrations may be
at greater risk for adverse pregnancy outcomes, includ-
ing fetal growth, but findings of the studies to date have
been inconsistent [1-3]. The relationship between DBP
exposure and reproductive health outcomes remains
unclear, mainly owing to limitations in the crude expo-
sure assessment in most studies [4-8]. Epidemiological
studies found mostly small increases in risk for low
birth weight (LBW) at term or small for gestational age
(SGA) [9-11] or yielded mixed results [12,13]. The epi-
demiological studies of reproductive outcomes have
relied on different methods of assessing exposure, which
presents difficulties in making comparisons between
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dies have attempted to improve exposure assessment by
using individual exposure measures combining routinely
collected water system THM measurements with a mea-
sure of ingestion, such as number of glasses or water
drank per day. However, only a few studies accounted
for spatial and temporal fluctuations in THM levels
across the distribution system over the time periods
relevant to study pregnancy [14,15]. Furthermore, seek-
ing to improve the exposure assessment, studies have
begun to incorporate behavioral determinants of differ-
ent routes of exposure to DBPs such as dermal absorp-
tion and inhalation during bathing and showering, and
ingestion of drinking water but the contribution of these
was unclear [16-18]. The recent epidemiological studies
concluded that, while there appears to be suggestive evi-
dence associating elevated total THM (TTHM) levels
with some adverse reproductive outcomes, evidence for
relationships with LBW and SGA are inconclusive and
inconsistent, and further research is warranted, includ-
ing on the importance of different exposure routes.
In the present study, we evaluated the effect of mater-
nal THM dose on several indices of fetal development.
Using prospective Kaunas cohort study with individual
d a t a ,w ew e r ea b l et oa d j u s tf o rm a n yi m p o r t a n tr i s k
factors for LBW and SGA. Through improvements in
individual THM exposure and dose assessment and con-
trolling for many possible confounding variables, our
study aims to offer estimated total individual internal
dose assessment based on monitoring of tap water
THM levels and detailed water use behaviors to examine
dose-response relationships for THMs and fetal growth.
Methods
Participant recruitment and outcome assessment
We conducted a prospective cohort study of pregnant
women in Kaunas city, Lithuania, as a part of the Eur-
opean Commission FP6 HiWATE Project Health
impacts of long-term exposure to DBP in drinking water
in Europe (HiWATE) [19].
On their first visit to a general practitioner, all preg-
nant women living in Kaunas city between 2007 and
2009 were invited to join the cohort. The women were
enrolled in the study only if they consented to partici-
pate in the cohort. The study ethics complied with the
Declaration of Helsinki [20]. The research protocol was
approved by the Lithuanian Bioethics Committee and an
oral informed consent was obtained from all subjects.
In total 5,405 women were approached; 79% of them
agreed to participate in the study. The first interview
was completed during the first pregnancy trimester.
The median gestational age at interview was 8 weeks.
The interview queried women regarding demographics,
residence and job characteristics, chronic diseases,
reproductive history, including date of last menstrual
period, previous preterm delivery. We also asked the
women to report their age (less than 20 years, 20-29
years, 30 years, and more), educational level (primary,
secondary, university), marital status (married not mar-
ried), smoking (non-smoker, smoker at least one cigar-
ette per day), alcohol consumption (0 drinks per week,
at least one drink per week), blood pressure (<140/
80 mm/Hg, ≥140 or ≥ 90 mm/Hg), body mass index
(<25 kg/m
2, 25-30 kg/m
2,> 3 0k g / m
2), and other poten-
tial risk factors for LBW. Adjustment for these variables
was made for studies of various birth outcomes sub-
groups. The women also were examined by ultrasound
to determine the gestational age of the fetus.
A special water consumption and water use habits
questionnaire was used to interview the 4,260 women
who agreed to participate in the study; 76.4% of them
were interviewed during the third pregnancy trimester
before delivery at the hospital and 23.6% by telephone
within the first month after delivery. Consumption was
ascertained for three types of water: cold tape water or
dinks made from cold tap water; boiled tap water (tea,
coffee, and other); and bottled water, used at home, at
work, other. In addition, number of showers, baths,
swimming pools weekly, and their average length was
asked of all subjects. The interviews were conducted by
trained nurses who did not know the THM exposure
status and birth outcome.
Pregnancy outcomes were abstracted from the medical
records. LBW were defined as infant’sB Wl e s st h a n
2,500 g. Infants were considered SGA if they were in
the lowest 10th centile of BW for each gestational week
stratified by infant gender and maternal ethnic group.
Gender-specific and ethnic group-specific deciles were
determined from the 2004 data set of all births in
Lithuania [21]. Women with multiple pregnancies (150),
having inconsistent or invalid data for dating the preg-
nancy (5) or estimating THM exposure (mostly students
moved out of the city during pregnancy, 839) or with
newborn BW above 4,500 g (75) were excluded. We
restricted our analyses to infants born with a BW below
4,500 g, leaving data for 3,341 women in the final
analysis.
We also conducted analyses comparing questionnaire
data and birth certificate data on various characteristics
among participants and non-participants. The mean
BW, gestational duration,p r e v a l e n c eo fL B Wa n dS G A
were similar among the two groups. These two groups
did not differed by ethnic group, consumption tap
water, showering, and bathing, however, nonparticipat-
ing mothers were younger (<20 years, 3.9% vs. 1.8%),
less educated (did not graduate from university, 46.6%
vs. 54.3%), more often smokers (smokers, 9.6% vs. 6.9%),
and did have fewer prior births (no child, 64.1% vs.
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the level of accuracy in personal reporting that can bias
the THM risk estimates, questionnaire information was
collected repeatedly on 10% subjects. There were no sig-
nificant differences in reporting water use habits and
other covariates.
Exposure Assessment
The Kaunas city municipal drinking water is supplied by
four water treatment plants system. The each treatment
plant water supplied system is constituted of only one
sub-system (i.e., one chlorination, and branchy water
supplied to the users). Groundwater sources are used
for the whole water supply system.
However, the four water treatment plants, which dis-
infected ground water with sodium hypochlorite (chlor-
ine dose 0.26-0.91 mg/L, residual chlorine 0-0.22 mg/L),
produced different concentrations of THMs in finished
water. One treatment plant (Petrasiunai) supplied fin-
ished water with higher levels of THMs ("high level
THM site,” 54.9% subjects), and the three other plants
supplied finished water with lower levels of all THMs
("low level THM site”). Water samples were collected
four times per year over a 3-year study period (2007-
2009) in the morning in three locations: close to the
treatment plant, at 5 km, and at 10 km or more from
every treatment plant. A total of 85 water samples were
collected from 12 monitoring sites in four water supply
zones for THM analysis. Samples were analysed at the
University of the Aegean, Greece, by using gas chroma-
tography with electron capture detection [22]. Measure-
ments included specific values for the four regulated
THMs (chloroform, bromoform, bromodichloro-
methane, and dibromochloromethane) and nine haloace-
tic acids (HAAs). Selected samples were analyzed for
five haloacetonitriles, two haloketones, chloropicrin, and
chloral hydrate. In addition, selected samples were ana-
lyzed at the National Institute for Health and Welfare
(THL), Finland, for the halogenated furanone MX. Only
THMs data were evaluated in this study since the other
halogenated DBPs were present only at low or sub μg/L
levels, if detected at all.
We calculated the mean quarterly THM constituent
concentrations for water zones and subsequently,
depending on the TTHM levels within each zone,
assigned “low level” and “high level” sites. We used tap
water THM concentration, derived as the average of
quarterly sample values over the time that the preg-
nancy occurred from all sampling sites located in the
each distribution system, and geocoded maternal
address at birth to assign the individual women residen-
tial exposure index. Estimates of exposure index to total
and specific THMs from drinking water were tabulated
first as an average level at the tap over the pregnancy
period; this measure was then categorized at the tertiles
of the distribution for birth outcomes. In addition, tri-
mester-specific analyses were conducted.
We combined every subject’s residential exposure
index and water-use questionnaire data to assess indivi-
dual exposure through ingestion of THMs. Women
were asked to indicate the cup or glass size and number
of cups or glasses of tap water consumed per day,
including hot and cold beverages made from tap water.
With this information, we calculated daily amounts of
hot and cold tap water ingested. Integration of the infor-
mation on residential THM levels (μg/L), ingested
amounts (L/day), and modifications by heating using an
estimated uptake factor of 0.00490 to derive an inte-
grated index of blood concentration, expressed in
micrograms per day (mg/d) [18,23].
The actual algorithms of internal dose from ingestion
were chloroform level (μg/l) × water consumption (l/
day) × 0.00490196 μg/μg/l; brominated THM level (μg/
l) × water consumption (l/day) × 0.00111848 μg/μg/l.
We assumed a null THM level for any bottled water
consumption since in local bottled water production
chlorination and ozonation is not used.
Finally, we addressed dermal absorption and inhala-
tion by considering showering and bathing alone and
combined with ingestion. We multiplied residential
THM levels (μg/L) by frequency and average duration of
bathing or showering per day (min/day) and calculated
each mother’s trimester-specific and entire pregnancy
average daily uptake of THM internal dose (mg/d). We
derived indices of daily uptake by integrating THM con-
centrations, duration of bathing and showering reported
in a questionnaire administered to study participants,
and estimated uptake factors of 0.001536 and 0.001321
of THMs in blood per minute per microgram from
showering and bathing, respectively [24,25]. The uptake
factors of THMs individual constituents were assessed
on the relative changes in blood levels after 10 minutes
exposure (after versus before ingestion 1 L of tap water,
10 minutes showering, and 10 minutes bathing).
The actual algorithms of internal dose from showering
and bathing were min/day showering × μg/l chloroform
in water × 0.001536261 μg/min/μg/l, min/day showering
× μg/l brominated THM in water × 0.001352065 μg/
min/μg/l, min/day bathing × μg/l chloroform in water ×
0.001320755 μg/min/μg/l, min/day bathing × μg/l bro-
minated THM in water × 0.00129571 μg/min/μg/l
We then used average daily total uptakes in our analy-
s i sa sc o n t i n u o u sa n dc a t e g o r i z e dv a r i a b l e s .W ec a l c u -
lated tertiles of THM internal dose. This gave first
(0.0025-0.0386 mg/d), second (0.0386-0.3496 mg/d), and
third (0.3496-2.4040 mg/d) tertiles for average TTHM
uptake. To reduce exposure misclassification errors in
the subsequent analysis, we used a subset of women
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address.
Analysis
The data analysis compared the LBW, SGA, and BW of
low, medium and high exposed women. We used logis-
tic regression to estimate adjusted odds ratios (ORs) and
95-percent confidence intervals (CIs) for LBW, SGA,
and the various exposure indices. We categorized
TTHM internal dose in tertiles and evaluated the possi-
ble relationship between increases in adverse birth out-
comes risk for an increase in estimated TTHM internal
dose. We ran multivariate logistic regression models for
the TTHMs, chloroform, dibromochloromethane, and
bromodichloromethane for the total pregnancy and tri-
mester-specific periods. We also used multiple linear
regressions for TTHM internal dose analysis as continu-
ous variable to evaluate the relationship, if any between
BW reductions and every 1 μg/d increase in TTHM
internal dose.
Risk factors for LBW have been reported extensively
elsewhere [26,27] and are not the subject of this article,
except to allow for appropriate control of covariates in
this analysis. In the logistic regression models for
adverse birth outcomes, using personal data of the
cohort sample, we assessed a variety of potential con-
founders identified by univariate analysis. Further, we
examined the association of THM exposure and birth
outcomes with a multivariable analysis controlling for
effect of major covariates that changed the adjusted ORs
for THM by 10% or more. The adjusted birth outcomes
analyses included family status, maternal education,
chronic diseases, body mass index, blood pressure,
smoking, alcohol consumption, ethnicity, previous pre-
term delivery, infant gender, and birth year. Two-tailed
statistical significance was evaluated by using a p value
of 0.05. All statistical analyses were carried out using
the SPSS software for Windows version 12.0.1.
Results
T h em e a nT T H Ml e v e li nt h el o wl e v e ls i t ef r o mt h r e e
water treatment plants was 1.3 μg/L, and in the high
level site (Petrasiunai) 21.9 μg/L (Table 1). The yearly
and seasonal fluctuations in the levels of TTHMs were
primarily the result of the lack of THM formation for
Petrasiunai in March, 2008. There was little spatial and
temporal variability within the high and low areas.
Chloroform was the dominant THM species in this
water, contributing approximately 80% of the mass of
the TTHMs. The brominated THM species were signifi-
cantly lower: dibromochloromethane ranged from 0.06
to 0.5 μg/L and bromodichloromethane ranged from 0.3
to 3.6 μg/L. Bromoform was below the limit of detec-
tion. The correlation between individual THM
concentrations was high (r = 0.91-0.99, p = 0.000) and
the correlations between each pregnancy trimester ran-
ged from 0.62 to 0.96, (p = 0.000).
Although there was a difference in the concentrations
of TTHMs between Petrasiunai and that of the other
sites, there was no difference in the levels of the other
halogenated DBPs, which were present at low or sub
μg/L levels, if detected at all. The mean sum (and stan-
dard deviation) of the dihalogenated and trihalogenated
HAAs for Petrasiunai was 0.5 (0.7) and 0.3 (0.7) μg/L,
respectively; whereas they were 0.3 (0.8) and 0.1 (0.2)
μg/L, respectively, for the other sites. The mean values
of other individual halogenated DBPs (i.e., haloacetoni-
triles, haloketones, chloropicrin, chloral hydrate, mono-
halogenated HAAs) were all less than 1.0 μg/L each for
Petrasiunai and the other sites. MX was only measured
once for Petrasiunai and it was not detected, whereas it
was measured three times in the other sites and was
0.6-1.5 ng/L. Thus, only THM data were evaluated in
this analysis, since there was a substantial difference in
THM occurrence between Petrasiunai and the other
sites.
The women recruited were predominantly Lithuanian
in ethnic origin (97.4%) and did not smoke (93.1%). The
mean age at enrolment was 28.4 years, and the women
tended to be highly educated (54.3% with a university
degree). The mean BW of the 3,341 singleton infants
included in our analysis was 3,445 g. Among these, 156
(4.7%) were classified as LBW and 270 (8.1%) as SGA.
The vast majority of SGA infants (93.0%) were term
births (37 weeks or above). In general, mothers who
smoked, were single, less educated, had previous pre-
term delivery, or suffered from a disease during preg-
nancy delivered a higher proportion of LBW or SGA
infants. We did not find a difference in fetal growth
between water filter users and non-users. The analysis
by TTHM internal dose tertiles showed, that most char-
acteristics of the exposure groups were similar (Table
2). There were no differences in social and demographic
characteristics, health behaviour, pregnancy history, and
maternal diseases. However, paternal smoking and alco-
hol consumption differed between exposure groups. The
proportion of LBW cases increased with increasing
THM exposure (3.7, 4.4 and 5.9%, respectively, low,
medium and high exposure). We also found an increase
in the proportion of SGA cases (7.0, 8.0 and 9.2%,
respectively).
Municipal water was the drinking water source of all
study subjects. Fifty-two percent of the women con-
sumed tap water and 12% of women reported consump-
tion of other tap-water beverages. Overall, women
consumed an average of 0.79 L of cold tap water, 1.04 L
of boiled water, and 1.09 L of bottled water per day.
The cohort study subjects’ daily water intake for water
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similar (Table 3). The highest amount of tap water was
consumed at home (0.62, 0.65, and 0.69 L, respectively,
low, medium, and high exposure), while at work and in
other places, tap water usage was low (mean 0.1 L).
Showering was common (96% of subjects) and 37%
took either shower or a bath during the pregnancy.
Mean frequency of showering was 6.5 times per week,
with a mean duration of 15.2 minutes per shower. Aver-
age frequency of bathing was 1.8 times per week, with a
mean duration of 33.5 minutes per bath. The percentage
of participants who attended swimming pools was low
(7%). The reporting of showering and bathing increased
with increasing THM exposure. The mean time of
showering was 69.73 minutes per week in the low-expo-
sure group, 92.21 minutes per week in the medium
exposure group, and 114.33 minutes per week in the
high exposure group. Mean bathing time also increased
with increasing exposure from 42.64 minutes per week
to 63.53 minutes per week.
THM integrated uptake included ingestion, showering,
and bathing. Uptake via ingestion contributed 8%; show-
ering and bathing were the main contributors for
TTHM and made up 92% of the total internal dose. The
variability in frequency and duration of showering and
bathing determined the TTHM internal dose variability.
The individual total uptake of TTHMs ranged
between 0.0025 and 2.40 mg/d. The total chloroform
uptake ranged between 0.0013 and 2.13 mg/d. Mothers
supplied with water who had a higher chloroform con-
centration generally also had a higher total internal
dose, and mothers supplied with water that had a lower
chloroform concentration generally also had a low total
internal dose. Daily uptake of bromodichloromethane
ranged between 0.0001 and 0.34 mg/d and dibromo-
chloromethane ranged between 0 and 0.064 mg/d.
Table 1 THM levels (μg/L) by sampling site, water supply zone, year and season of sampling
Tap water sampling TTHMs
cMean (SD
d) CHCl3Mean (SD) CHBr2Cl Mean (SD) CHBrCl2 Mean (SD)
Sampling sites
All sites 9.8 (12.4) 7.8 (10.2) 0.3 (0.5) 1.7 (2.2)
Low THM level
a 1.3 (1.2) 0.9 (1.0) 0.1 (0.2) 0.3 (0.5)
High THM level
b 21.9 (10.9) 17.7 (9.0) 0.5 (0.6) 3.6 (2.1)
Year of sampling
2007 all sites 10.3 (13.5) 8.7 (12.0) 0 (0
e) 1.5 (1.6)
Low THM level
a 0.9 (1.3) 0.39 (1.0) 0 (0) 0.6 (0.5)
High THM level
b 24.2 (11.0) 21.3 (9.6) 0 (0) 2.9 (1.7)
2008 all sites 6.2 (10.2) 4.4 (7.5) 0.3 (0.5) 1.5 (2.4)
Low THM level
a 1.5 (1.1) 0.9 (0.6) 0.2 (0.3) 0.5 (0.5)
High THM level
b 12.7 (13.5) 9.3 (9.8) 0.6 (0.6) 2.8 (3.3)
2009 all sites 11.8 (12.8) 9.5 (10.0) 0.4 (0.5) 1.9 (2.3)
Low THM level
a 1.3 (1.1) 1.3 (1.0) 0.1 (0.2) 0.1 (0.2)
High THM level
b 26.5 (2.9) 21.0 (2.3) 0.9 (0.4) 4.6 (0.5)
Season of sampling
Spring all sites 8.5 (12.1) 6.8 (9.7) 0.3 (0.4) 1.4 (2.1)
Low THM level
a 1.4 (1.3) 1.2 (1.1) 0.1 (0.3) 0.2 (0.4)
High THM level
b 18.3 (13.6) 14.7 (10.9) 0.5 (0.5) 3.1 (2.3)
Summer all sites 9.9 (12.7) 8.3 (11.3) 0 (0) 1.6 (1.7)
Low THM level
a 1.0 (1.4) 0.4 (1.0) 0 (0) 0.7 (0.5)
High THM level
b 24.1 (8.3) 21.0 (7.0) 0 (0) 3.1 (2.0)
Autumn all sites 11.1 (13.4) 8.8 (11.1) 0.2 (0.5) 2.0 (2.4)
Low THM level
a 1.2 (1.1) 0.8 (0.9) 0 (0) 0.4 (0.5)
High THM level
b 24.8 (9.7) 20.1 (8.6) 0.6 (0.6) 4.2 (2.4)
Winter all sites 10.9 (12.1) 8.4 (9.3) 0.5 (0.6) 1.9 (9.3)
Low THM level
a 1.1 (1.0) 0.9 (0.6) 0.1 (0.3) 0.1 (0.3)
High THM level
b 24.5 (1.4) 18.9 (1.2) 1.1 (0.1) 4.5 (0.2)
aViciunai, Eiguliai, Kleboniskis.
bPetrasiunai.
cTTHMs = total trihalomethanes: the sum of CHCl3 (chloroform),
CHBr2Cl (dibromochloromethane), and CHBrCl2 (bromodichloromethane).
dSD = standard deviation.
e0 = below the limit of detection.
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uptake tertile dose levels of TTHMs and trimester-spe-
cific levels. The correlation coefficient between TTHM
uptake in the first and second trimester was 0.98, p <
0.001, and between the first and third trimester was
0.95, p < 0.001. A similar strong correlation was found
for the uptake of THM constituents between the preg-
nancy trimesters (r = 0.99-0.81). The strong correlation
is a result of limited variability in the amount of THMs
produced from season to season at these groundwater
treatment plants.
Exposure to TTHMs was associated with an increased
risk for LBW using tertiles and a reduction in BW using
a continuous variable (Table 4). After adjustment for
potential confounding factors, we observed a statistically
significant increased risk with higher dose levels (second
and third tertiles) of TTHMs during the three trimesters
and entire pregnancy. During the entire pregnancy, the
odds ratios for LBW were 1.77, 95% CI 0.95-3.30; and
OR 2.13, 95% CI 1.17-3.87, respectively, for second and
third tertiles compared to the first tertile. The LBW risk
(OR) observed per 0.1 μg/d increase in TTHMs was
Table 2 Distribution of Kaunas cohort study subjects for
various characteristic by exposure
Risk factor/
outcome
Low THM N
(%)
Medium THM N
(%)
High THM N
(%)
Maternal age
< 20 years 19 (1.8) 17 (1.5) 23 (2.1)
20-29 years 652 (60.1) 688 (59.7) 658 (59.6)
≥ 30 years 414 (39.2) 447 (38.8) 423 (38.3)
Marital status
Married 876 (80.7) 958 (83.2) 910 (82.4)
Not married 209 (19.3) 194 (16.8) 194 (17.6)
Maternal education
Primary school 59 (5.4) 50 (4.3) 57 (5.2)
Secondary
school
454 (41.8) 465 (40.4) 442 (40.0)
University
degree
572 (52.7) 637 (55.3) 605 (54.8)
Maternal
smoking
Nonsmoker 1003 (92.4) 1076 (93.4) 1031 (93.4)
Smoker 82 (7.6) 76 (6.6) 73 (6.6)
Paternal smoking
a
Nonsmoker 574 (53.4) 629 (55.4) 545 (49.8)
Smoker 501 (46.6) 507 (44.6) 550 (50.2)
Alcohol
consumption
a
No 1000 (92.2) 1094 (95.0) 1048 (94.9)
Yes 85 (7.8) 58 (5.0) 56 (5.1)
Blood pressure
<140/80 mm/Hg 969 (89.3) 1020 (88.5) 977 (88.5)
≥140 or ≥ 90
mm/Hg
116 (10.7) 132 (11.5) 127 (11.5)
Ethnic group
Lithuanian 1054 (97.1) 1117 (97.0) 1082 (98.1)
Other 31 (2.9) 35 (3.0) 21 (1.9)
Parity
No child 492 (45.3) 499 (43.3) 516 (46.7)
≥ 1 child 593 (54.7) 653 (56.7) 588 (53.3)
Infant gender
Male 559 (51.5) 611 (53.0) 544 (49.3)
Female 526 (48.5) 541 (47.0) 560 (50.7)
Current residence
1-4 years 437 (40.3) 492 (42.7) 472 (42.8)
5-9 years 257 (23.7) 288 (25.0) 296 (26.8)
≥ 10 years 391 (36.0) 372(32.3) 336 (30.4)
Work exposure
No 996 (91.8) 1053 (91.4) 999 (90.5)
Yes 89 (8.2) 99 (8.6) 105 (9.5)
Chronic disease
No 825 (76.0) 858 (74.5) 844 (76.4)
Yes 260 (24.0) 294 (25.5) 260 (23.6)
Table 2 Distribution of Kaunas cohort study subjects for
various characteristic by exposure (Continued)
Previous preterm
delivery
No 1069 (98.5) 1123 (97.5) 1087 (98.5)
Yes 16 (1.5) 29 (2.5) 17 (1.5)
Socio economic
status
Low income 335 (30.9) 337 (29.3) 338 (30.6)
Medium income 582 (53.6) 642 (55.7) 600 (54.3)
High income 168 (15.5) 173 (15.0) 166 (15.0)
Body mass index (kg/m
2)
<25 Normal 618 (57.0) 677 (58.8) 679 (61.5)
25-30
Overweight
329 (30.3) 334 (29.0) 284 (25.7)
30 Obesity 138 (12.7) 141 (12.2) 141 (12.8)
Water filter
Yes 341 (31.4) 336 (29.2) 338 (30.6)
No 744 (68.6) 816 (70.8) 766 (69.4)
LBW
a
Yes 40 (3.7) 51 (4.4) 65 (5.9)
No 1045 (96.2) 1101 (95.7) 1039 (94.1)
SGA
Yes 76 (7.0) 92 (8.0) 102 (9.2)
No 1009 (93.0) 1060 (92.0) 1002 (90.8)
Mean birth weight
(SDs)
3449 (517) 3462 (524) 3430 (559)
ap < 0.05.
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Page 6 of 111.08, 95% CI 1.01-1.16 and 1.07, 95% CI 1.00-1.15; and
decrease in BW was 49.3 g (-146.3 to -1.5) and 47.2 g
(-92.7 to -1.6) during the entire pregnancy and third tri-
m e s t e r .S i m i l a r l y ,f i r s t ,s e c o n d ,a n dt h i r dt r i m e s t e r s
chloroform dose categories were associated with a statis-
tically significant increase in the risk for LBW. Chloro-
form analyzed as continuous variable (increase of 0.1
μg/d) was also associated with an increase in risk for
LBW (OR 1.10, 95% CI 1.01-1.19) for the entire preg-
nancy, as well as for trimester-specific time windows. In
a linear regression we found a mean decrease in BW of
59.3 g (-114.8 to -3.7) for the entire pregnancy and 57.8
g (-111.6 to -4.0) for the third trimester, respectively,
with increasing dose levels of chloroform. For bromodi-
chloromethane, we observed statistically significant
increases in LBW risk for the third tertile compared to
the first tertile for the third trimester, OR 1.80, 95% CI
1.00-3.26. For bromodichloromethane internal dose as a
continuous variable, we found an elevated risk in LBW
for the entire pregnancy, first and third trimesters (ORs
1.04-1.05 for an increase of every 0.01 μg/d). The dibro-
mochloromethane internal dose results were statistically
significant for entire pregnancy and third trimester (OR
2.52, 95% CI 1.00-6.36 and OR 2.42, 95% CI 1.03-5.66,
respectively). No significant reduction in BW as a con-
tinuous variable was found.
We found slight a increase in the risk of SGA related
to elevated internal doses of THMs, hovewer, the results
were statistically non-significant (Table 5). We observed
slight increases in the risk for SGA among TTHMs
exposed women (ORs 1.13-1.34). Chloroform dose was
also associated with a slight increases in the risk of SGA
(OR 1.19, 95% CI 0.87-1.63 and OR 1.22, 95% CI 0.89-
1.68, respectively, for second and third tertile of third
trimester and OR 1.04, 95% CI 1.00-1.09 per every 0.1
μg/d increase in the chloroform internal dose). Bromo-
dichloromethane internal dose was associated with an
increased risk but this was not monotonic (OR 1.37,
95% CI 1.00-1.88 and OR 1.25, 95% CI 0.91-1.73,
respectively, for second and third tertile of third trime-
ster), and it was not statistically significant as a continu-
ous variable (OR 1.20, 95% CI 0.90-1.62).
Discussion
We conducted a prospective cohort study to examine
the effects of internal dose of THM during the entire
pregnancy and during three trimesters on LBW, BW,
and SGA births. We observed a low spatial variation in
THM levels measured in three locations: close to the
treatment plant, at 5 km and at 10 km or more from
every treatment plant in the each distribution system.
The low spatial variability of TTHM present in Kaunas
groundwater distribution systems could be explained by
the relatively simple structure (i.e. one subsystem) and
low presence of DBPs precursors at the groundwater
sources [4,28]. Personal behavior was the main determi-
nant of exposure variability of the study subjects. Uptake
via showering and bathing provided a greater contribu-
tion to the uptake of the TTHM to the internal dose
than did ingestion of tap water (92 and 8%, respectively).
We demonstrated consistent, statistically significant
effects of THM exposure on LBW and BW with an indi-
cation of dose-response relation. We found both excess
risk of LBW during the entire pregnancy and during
three trimesters as well. Specifically, there was a statisti-
cally significant excess risk of LBW for those exposed to
higher internal doses of TTHM and chloroform in the
three trimesters and a slight excess risk for those
exposed to higher internal doses of bromodichloro-
methane and dibromochloromethane during the entire
pregnancy and during third trimester. TTHM constitu-
ents (chloroform, bromodichloromethane and dibromo-
chloromethane) analysed as categorical variables showed
a slight excess risk of SGA during the entire pregnancy
as well as trimester-specific periods. The probability of
delivering an SGA infant was elevated by 4% per every
0.1 μg/d increase in the chloroform internal dose during
Table 3 Summary of Kaunas cohort study subjects daily
water intake for water users by THM exposure
Mean daily ingestion (L/day) Low THM Medium
THM
High THM
Mean SD Mean SD Mean SD
Consumption tap water
(52.1%)
a
At home 0.62 0.43 0.65 0.48 0.69 0.49
At work 0.10 0.23 0.10 0.24 0.11 0.25
Other 0.02 0.09 0.02 0.09 0.02 0.11
In total 0.74 0.52 0.77 0.11 0.82 0.60
Other tap-water beverages
(12.2%)
a
At home 0.36 0.35 0.39 0.37 0.37 0.38
At work 0.09 0.18 0.07 0.17 0.07 0.15
Other 0.05 0.12 0.07 0.21 0.06 0.16
In total 0.50 0.37 0.53 0.42 0.50 0.41
Consumption bottled water
(78.1%)
a
At home 0.61 0.51 0.70 0.54 0.61 0.56
At work 0.35 0.38 0.38 0.40 0.39 0.39
Other 0.06 0.16 0.06 0.20 0.06 0.17
In total 1.01 0.69 1.14 0.75 1.07 0.76
Boiled water (tea, coffee)
(95%)
a
At home 0.51 0.30 0.53 0.30 0.51 0.32
At work 0.28 0.29 0.29 0.29 0.30 0.28
Other 0.05 0.13 0.05 0.14 0.05 0.13
In total 0.84 0.47 0.87 0.46 0.87 0.46
a% of individuals reporting daily water ingestion.
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Page 7 of 11the third trimester pregnancy. The lack of statistically
significant effects for other TTHM constituents may be
due to low exposure because of low levels, and lack of
power in our study sample.
Although the third trimester is the most important in
terms of fetal body mass growth, it has been hypothe-
sized that early-pregnancy exposure may hamper fetal
growth [15]. Therefore we conducted analyses exploring
effects for three trimester-specific gestational exposures
and entire pregnancy exposures. In our analyses it was
more difficult to evaluate any independent effects of the
trimesters because of the high correlation in exposure
between them.
The epidemiological evidence for an association
between exposure to THM and indicators of fetal
growth is relatively inconsistent. A number of prior
investigations have evaluated crude exposure during the
third trimester of pregnancy, the time period of gesta-
tion when fetal growth may be most sensitive to envir-
onmental influences. No associations were reported
between term LBW and trimester-specific exposures or
entire pregnancy exposures to TTHM [9,10]. Investiga-
tors who were able to address variation in residential
exposures observed a positive association between
TTHM exposures and term LBW, decreased mean BW
and increased risk of delivering a LBW infant despite
low TTHM concentrations [29,30]. Others find a weak
association of SGA with an exposure level of THM of
30 mg/L [31]. Some epidemiological studies reported a
moderately increased risk of delivering a SGA infant
among women exposed to high levels of TTHM, with
relative risks ranging up to 1.5 [10-12,16].
An association between increased risk of intrauterine
growth retardation and TTHM exposure was reported
[10] and a dose-response trend was observed for expo-
sure to chloroform [32]. Some authors did find a slightly
elevated risk of intrauterine growth retardation during
the second and third trimesters for TTHM [15] and
others did not [33]. These studies differed in their expo-
sure estimation because they mainly used the routinely
Table 4 LBW adjusted odds ratio and BW change for gestational exposure to internal dose THMs
THM exposure Tertile
limits (mg/d)
LBW
cases
Non
LBW
Entire pregnancy OR
a
(95% CI)
First trimester OR
(95% CI)
Second trimester OR
(95% CI)
Third trimester OR
(95% CI)
TTHM
b
0.0025-0.0386 40 1046 Reference Reference Reference Reference
0.0386-0.3545 51 1099 1.77 (0.95-3.30) 1.94 (1.04-3.62) 1.71 (0.92-3.18) 2.31 (1.22-4.35)
0.3545-2.4040 65 1040 2.13 (1.17-3.87) 2.29 (1.24-4.22) 2.06 (1.14-3.73) 2.12 (1.14-3.92)
Continuous (0.1 μg/d) 1.08 (1.01-1.16) 1.08 (1.01-1.16) 1.07 (1.00-1.15) 1.07 (1.00-1.15)
Change in BW
c g -49.3
d (-146.3 - -1.5) -45.7
d (-91.4-0.0) -45.3 (-92.8-2.2) -47.2
d (-92.7 - -1.6)
Chloroform
0.0013-0.0249 40 1050 Reference Reference Reference Reference
0.0249-0.2868 52 1093 2.06 (1.10-3.85) 2.30 (1.21-4.36) 1.79 (0.95-3.36) 2.12 (1.11-4.02)
0.2868-2.1328 64 1042 2.17 (1.19-3.98) 2.41 (1.30-4.49) 2.13 (1.18-3.85) 2.13 (1.15-3.92)
Continuous (0.1 μg/d) 1.10 (1.01-1.19) 1.10 (1.02-1.18) 1.10 (1.01-1.18) 1.09 (1.01-1.18)
Change in BW
c g -59.3
d (-114.8 - -3.7) -52.8
d (-104.4 - -1.2) -53.4 (-108.2-1.3) -57.8
d (-111.6 - -4.0)
CHBrCl2
0.0001-0.0124 45 1046 Reference Reference Reference Reference
0.0124-0.0501 53 1093 1.83 (1.01-3.34) 1.93 (1.05-3.55) 1.95 (1.07-3.58) 1.64 (0.89-3.02)
0.0501-0.3359 58 1046 1.64 (0.90-2.98) 2.06 (1.11-3.80) 1.82 (0.99-3.35) 1.80 (1.00-3.26)
Continuous (0.01 μg/d) 1.05 (1.00-1.11) 1.05 (1.00-1.11) 1.05 (0.99-1.11) 1.04 (1.00-1.10)
Change in BW
e g -28.2 (-63.2-6.9) -29.7 (-67.5-8.0) -27.7 (-63.2-7.7) -25.7 (-57.2-5.8)
CHBr2Cl
0.0000-0.0000 57 1058 Reference Reference Reference Reference
0.0000-0.0039 49 1075 3.02 (1.23-7.40) 0.62 (0.28-1.37) 0.68 (0.31-1.46) 2.44 (1.05-5.70)
0.0039-0.0644 50 1052 2.52 (1.00-6.36) 0.74 (0.37-1.49) 0.78 (0.36-1.67) 2.42 (1.03-5.66)
Continuous (0.01 μg/d) 1.18 (0.85-1.65) 1.06 (0.73-1.54) 1.16 (0.84-1.61) 1.23 (0.93-1.61)
Change in BW
e g -24.3 (-215.7-167.2) 15.5 (-197.0-228.1) -18.8 (-203.3-165.7) -45.9 (-207.6-114.8)
aadjusted for squared gestational age, marital status, maternal education, chronic diseases, body mass index, blood pressure, smoking, alcohol consumption,
previous preterm delivery, infant gender, and birth year.
bTTHM, total trihalomethane; CHBrCl2, bromodichloromethane; CHBr2Cl, dibromochloromethane.
cChange in birth weight in grams, of infants below 3,500 g, for every 1 μg/d increase in THMs internal dose.
dp < 0.05.
eChange in birth weight in grams, of infants below 3,500 g, for every 0.1 μg/d increase in THMs internal dose.
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data. Lack of a consistent significant effect of the epide-
miologic studies may be result of a study design, be a
result of exposure misclassification or inadequate control
for confounding variables, or a lack of power in studies
sample, or actual lack of an effect of DBP on fetal growth.
A recent meta-analysis of epidemiological studies data
on the association of TTHM concentration in water and
fetal growth, without taking into account showering,
bathing, and other exposure routes, concluded that
there was little or no evidence for associations between
TTHM concentration and fetal growth and that the
uncertainties-relating particularly to exposure may have
affected the results. The authors concluded that there is
need a more accurate exposure assessment in the stu-
dies of the associations between TTHM and birth out-
comes [34,35].
Only few studies have incorporated information on
individual water use to estimate personal DBP exposure
[16,19,36]. However, personal exposure analyzed as cate-
gorical variable did not show a stronger association than
residential concentration with respect to fetal growth
and fetal survival outcomes. These studies did not
explore the effect of THMs as continuous variables on
LBW or SGA risk. Recently, findings of a case-control
study suggested that exposure to THMs at the highest
levels can affect fetal growth but only in genetically sus-
ceptible newborns [37].
Our study offered advancement in individual internal
dose assessment based on residential THM levels,
detailed water use behaviors and exposure during preg-
nancy. Every subject’s exposure indices were estimated
as daily internal dose of the THM constituents (mg/d)
and birth outcome effects were assessed by using indices
categorical variable and also as a continuous variable.
An additional strength of our study is that pregnant
women were prospectively followed, and did not move
during pregnancy. This allowed collection of self-
reported data on potential confounding covariates. How-
ever, there is a possibility of residential confounding in
our study, because we did not adjusted for e.g. residen-
tial air pollution exposure that might have effect on
adverse birth outcomes [38]. An additional limitation of
our study is because of lack information on maternal
nutrition and infection diseases. This study exposure
assessment also could be improved by more frequent
measurement of DBPs at the every home tap and
including other water usage activities and validation of
data on DBP blood concentration measurement, but this
is prohibitive expensive. Furthermore, lack of informa-
tion regarding the validity of the internal dose assess-
ment models that we used is one of the limitations of
this study, but again validity studies are difficult to con-
duct and are expensive.
In this study, despite low concentrations of THM in
drinking water, we found evidence of fetus growth
Table 5 SGA adjusted odds ratio for gestational exposure to internal dose THMs
THM exposure Tertile
limits (mg/d)
SGA
cases
Non
SGA
Entire pregnancy OR
a
95% CI
First trimester OR
a
95% CI
Second trimester OR
a
95% CI
Third trimester OR
a
95% CI
TTHM
b
0.0025-0.0386 76 1010 Reference Reference Reference Reference
0.0386-0.3545 92 1058 1.18 (0.86-1.82) 1.13 (0.82-1.54) 1.18 (0.86-1.62) 1.17 (0.85-1.60)
0.3545-2.4040 102 1003 1.34 (0.98-1.84) 1.27 (0.93-1.73) 1.33 (0.97-1.82) 1.22 (0.89-1.67)
Continuous 0.1 μg/L 1.03 (0.99-1.07) 1.02 (0.98-1.06) 1.03 (0.99-1.07) 1.02 (0.98-1.06)
Chloroform
0.0013-0.0249 78 1012 Reference Reference Reference Reference
0.0249-0.2868 91 1054 1.16 (0.84-1.59) 1.19 (0.86-1.63) 1.12 (0.82-1.54) 1.19 (0.87-1.63)
0.2868-2.1328 101 1005 1.31 (0.96-1.79) 1.30 (0.95-1.77) 1.28 (0.94-1.74) 1.22 (0.89-1.68)
Continuous 0.1 μg/L 1.03 (0.99-1.08) 1.03 (0.99-1.08) 1.03 (0.99-1.08) 1.04 (1.00-1.09)
CHBrCl2
0.0001-0.0124 73 1018 Reference Reference Reference Reference
0.0124-0.0501 101 1045 1.35 (0.99-1.86) 1.21 (0.88-1.67) 1.20 (0.88-1.65) 1.37 (1.00-1.88)
0.0501-0.3359 96 1008 1.29 (0.94-1.78) 1.35 (0.99-1.85) 1.23 (0.90-1.69) 1.25 (0.91-1.73)
Continuous 0.01 μg/L 1.21 (0.90-1.62) 1.19 (0.87-1.62) 1.19 (0.89-1.60) 1.20 (0.90-1.62)
CHBr2Cl
0.0000-0.0000 102 1013 Reference Reference Reference Reference
0.0000-0.0039 78 1045 0.77 (0.56-1.05) 0.76 (0.54-1.07) 0.66 (0.48-0.91) 1.76 (0.56-1.03)
0.0039-0.0644 90 1012 0.89 (0.66-1.21) 0.88 (0.67-1.17) 0.90 (0.68-1.21) 0.85 (0.63-1.15)
Continuous 0.01 μg/L 1.05 (0.89-1.24) 1.05 (0.86-1.26) 1.05 (0.86-1.26) 1.06 (0.92-1.22)
aadjusted for: previous preterm delivery, maternal education, marital status, smoking, alcohol consumption, body mass index, maternal age, parity, and birth year.
bTTHM, total trihalomethane; OR, odds ratio; CI, confidence intervals; CHBr2Cl, dibromochloromethane; CHBrCl2, bromodichloromethane.
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doses after controlling for family status, maternal educa-
tion, chronic diseases, body mass index, blood pressure,
smoking, alcohol consumption, previous preterm, infant
gender, and year. However, the trihalomethanes are not
the only by-products of chlorine disinfection or other
contaminants, although in this region the levels of other
by-products appeared to be very low, we cannot exclude
the potential effects of this low-dose mixture, or any
other related exposure.
The health effects of LBW and SGA are important
issue for public health since these infants are at an
increased risk of significant morbidity and mortality
during the early stages of life.
Conclusions
This study presented some epidemiological evidence for
a dose-response relationship between THM internal
dose exposure and LBW; a statistically significant asso-
ciation of THM with SGA was seen only for chloroform
exposure. Our study used the questionnaire information
to evaluate of pregnant women water usage habits and
estimate integrated internal dose for THM exposure
assessment. Our data showed that seeking to reduce
exposure measurement errors in individual exposure
determination, assigning exposure through dermal
absorption, and inhalation should be considered com-
bined with ingestion, since TTHM through ingestion
composed less than 10% of integrated internal dose.
This study finding suggest that internal dose in preg-
nancy vary substantially across individuals, depending
on both water THM levels and water use habits and
that internal dose may affect fetal growth. However, we
do not feel this study provides strong support that any
THM constituent is associated with fetal growth restric-
tion. Futher research should focus on the use of inte-
grated internal dose and individual susceptibility in the
study of DBP effects on birth outcomes.
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